Prostate brachytherapy, or “close treatment”, is less common than external beam radiotherapy for prostate cancer. However, it is a highly effective technique. Cancer Care Ontario adapted and adopted its guidelines with the American Society of Clinical Oncology (ASCO). For the May #radonc journal club, we will learn about prostate brachytherapy’s current indications for curative treatment and future directions. Our article is free for download:
Please join Dr. Andrew Loblaw and colleagues this coming weekend, May 20-21 starting 6AM Central Standard Time on Saturday May 20 and carry through into Sunday May 21st. Scheduling a ‘live hour’ is still in the works. Thanks to the Journal of Clinical Oncology, the article is already open access.
Here are our topic questions:
T1. What is prostate brachytherapy, and how is it currently used in prostate cancer patients?
T2. What is the current evidence for prostate brachytherapy for low risk, early stage prostate cancer?
T3. What is the current evidence for prostate brachytherapy for higher risk prostate cancer
T4. What factors contribute to its current use in clinical practice?
T5. What are the key areas for future prostate brachytherapy research and use in clinical practice?
- Here are guidelines on how to sign up and participate
- Read our disclaimer for ways to keep it rewarding and professional. If you’re not ready, just lurk and tune into the conversation.
Any suggestions? Leave a comment or tweet us at @Rad_Nation. We look forward to having you join us!